How should dual antiplatelet therapy be managed in a patient with a recent myocardial infarction and subdural hematoma who has never undergone coronary imaging (e.g., coronary CT angiogram)?

Management of Dual Antiplatelet Therapy in Recent MI with Subdural Hematoma

In a patient with recent myocardial infarction and subdural hematoma who has not undergone coronary imaging, you must immediately discontinue both antiplatelet agents, stabilize the subdural hematoma with neurosurgical consultation, and then perform urgent coronary angiography to determine if stenting occurred or is needed—this will dictate whether DAPT can be safely withheld or must be cautiously resumed.

Immediate Management Algorithm

Step 1: Assess Hemorrhage Severity and Discontinue DAPT

• Stop both aspirin and P2Y12 inhibitor immediately when major intracranial hemorrhage is identified 1
• Obtain urgent neurosurgical consultation to determine if the subdural hematoma requires surgical evacuation
• Stabilize hemodynamics and correct coagulopathy with platelet transfusions if needed 2

The ESC guidelines demonstrate through Case #1 that even with recent stent placement, both antiplatelet agents can be discontinued in the face of life-threatening hemorrhage, though this creates substantial thrombotic risk 1.

Step 2: Determine Coronary Anatomy and Intervention Status

This is the critical missing piece in your scenario. You must urgently clarify:

• Was a stent placed during the MI? If yes, what type (bare metal vs drug-eluting) and when?
• If no stent was placed, was the MI managed medically or with thrombolysis only?
• Perform coronary angiography if not yet done to assess:
  • Presence and location of culprit lesion
  • Whether intervention is absolutely necessary
  • Feasibility of non-stent strategies

Step 3: Risk Stratification for Thrombosis vs Bleeding

High thrombotic risk scenarios (favor earlier DAPT resumption):

• Stent placed within the last 30 days 3, 4
• Drug-eluting stent of any age
• Complex PCI (long stents, bifurcation, left main)
• Acute coronary syndrome presentation 5

High bleeding risk scenarios (favor delayed DAPT resumption):

• Expanding subdural hematoma
• Need for neurosurgical intervention
• Hemodynamic instability from bleeding
• Elderly patient with multiple comorbidities 2

Step 4: Tailored Intervention Strategy

If stent is already in place:

• Resume aspirin alone as soon as neurosurgically safe (typically 24-72 hours after hemorrhage control) 1
• Consider cangrelor (IV P2Y12 inhibitor) if available—it can be rapidly discontinued if rebleeding occurs 6
• The ESC case showed successful resumption of DAPT just 3 hours after endoscopic control of GI bleeding, though this was followed by stent thrombosis when doses were missed 1
• Critical timing: Stent thrombosis carries 20-45% mortality and 64% risk of death or MI 3

If no stent yet placed:

• Strongly consider plain balloon angioplasty (POBA) without stenting to avoid mandatory DAPT requirement 6
• This allows aspirin monotherapy or even temporary cessation of all antiplatelets
• Accept higher restenosis risk to avoid catastrophic stent thrombosis if DAPT must be stopped

If medical management only:

• Resume aspirin alone when bleeding stabilized
• Avoid P2Y12 inhibitor entirely until subdural hematoma resolved (typically 4-6 weeks)

Special Considerations and Pitfalls

The "No Coronary Imaging" Problem

Without knowing coronary anatomy, you're flying blind on thrombotic risk. Coronary CT angiography is insufficient here—you need invasive angiography to:

• Visualize thrombus burden
• Assess collateral flow
• Determine if intervention can be deferred
• Guide stent vs no-stent decision

Neurosurgical Coordination

• Middle meningeal artery embolization is an emerging technique that may allow earlier DAPT resumption in chronic subdural hematoma 7
• Traditional craniotomy requires 5-7 days of antiplatelet cessation for clopidogrel/prasugrel, 3 days for ticagrelor 4

The Timing Paradox

The ESC guidelines recommend minimum 1 month DAPT after any stent and ideally 12 months after MI 3, 4, 5. However, Case #1 demonstrates that even 39 hours off DAPT can cause fatal stent thrombosis 1. This creates an impossible situation when major bleeding occurs.

Monitoring Strategy

If DAPT is resumed:

• Daily neurological examinations
• Serial CT scans (day 1,3,7) to detect rebleeding
• Proton pump inhibitor to reduce GI bleeding risk 1
• Avoid NSAIDs, anticoagulation, and other bleeding risk factors

The Hard Truth

This scenario has no good options—only less bad ones. The 2018 ESC guidelines acknowledge this is "navigating between the risks of stent thrombosis and major hemorrhage" 1. Your decision tree must prioritize:

1. Mortality risk: Subdural hematoma expansion vs stent thrombosis (both ~20-45% fatal)
2. Reversibility: Subdural hematoma may resolve; stent thrombosis causes permanent myocardial damage
3. Time sensitivity: Thrombotic risk highest in first 30 days; bleeding risk decreases as hematoma organizes

The absence of coronary imaging makes this decision nearly impossible to optimize. Obtain angiography urgently, involve neurosurgery immediately, and if intervention is needed, strongly favor balloon angioplasty over stenting to minimize DAPT dependence 6.